Impact of etiology on the outcomes in heart failure patients treated with cardiac resynchronization therapy: A meta-analysis

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Chen, Yanmei ^a   Duan, Chongyang ^a   Liu, Feng ^a   Shen, Shuxin ^a   Chen, Pingyan ^a   Bin, Jianping ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; DRUG EFFICACY; ECHOCARDIOGRAPHY; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; ISCHEMIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; META ANALYSIS; MORTALITY; OBSERVATIONAL STUDY; RISK FACTOR; SENSITIVITY ANALYSIS; TREATMENT OUTCOME; HEART LEFT VENTRICLE FUNCTION; HOSPITALIZATION; PATHOPHYSIOLOGY; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK;

CARDIAC RESYNCHRONIZATION THERAPY; ECHOCARDIOGRAPHY; HEART FAILURE; HOSPITALIZATION; HUMANS; OBSERVATIONAL STUDY AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT;

EID: 84899628116     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0094614     Document Type: Article

References (43)

1. McAlister FA, Ezekowitz J, Hooton N, Vandermeer B, Spooner C, et al. (2007) Cardiac resynchronization therapy for patients with left ventricular systolic dysfunction: a systematic review. JAMA 297: 2502-2514. (Pubitemid 46953404)
2. Stevenson WG, Hernandez AF, Carson PE, Fang JC, Katz SD, et al. (2012) Indications for cardiac resynchronization therapy: 2011 update from the Heart Failure Society of America Guideline Committee. J Card Fail 18: 94-106.
3. van Bommel RJ, Bax JJ, Abraham WT, Chung ES, Pires LA, et al. (2009) Characteristics of heart failure patients associated with good and poor response to cardiac resynchronization therapy: a PROSPECT (Predictors of Response to CRT) sub-analysis. Eur Heart J 30: 2470-2477.
4. Delgado V, van Bommel RJ, Bertini M, Borleffs CJ, Marsan NA, et al. (2011) Relative merits of left ventricular dyssynchrony, left ventricular lead position, and myocardial scar to predict long-term survival of ischemic heart failure patients undergoing cardiac resynchronization therapy. Circulation 123: 70-78.
5. Ypenburg C, Schalij MJ, Bleeker GB, Steendijk P, Boersma E, et al. (2007) Impact of viability and scar tissue on response to cardiac resynchronization therapy in ischaemic heart failure patients. Eur Heart J 28: 33-41. (Pubitemid 46134955)
6. Leclercq C, Singh JP (2011) Cardiac resynchronization therapy: from treatment to prevention. Eur Heart J 32: 1580-1582.
7. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, et al. (2004) Cardiacresynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 350: 2140-2150.
8. Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, et al. (2005) The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 352: 1539-1549. (Pubitemid 40517094)
9. Gasparini M, Mantica M, Galimberti P, Genovese L, Pini D, et al. (2003) Is the outcome of cardiac resynchronization therapy related to the underlying etiology? Pacing Clin Electrophysiol 26: 175-180. (Pubitemid 36399134)
10. Waggoner AD, Rovner A, de Las FL, Faddis MN, Gleva MJ, et al. (2006) Clinical outcomes after cardiac resynchronization therapy: importance of left ventricular diastolic function and origin of heart failure. J Am Soc Echocardiogr 19: 307-313. (Pubitemid 43267455)
11. Di Biase L, Auricchio A, Sorgente A, Civello K, Klersy C, et al. (2008) The magnitude of reverse remodelling irrespective of aetiology predicts outcome of heart failure patients treated with cardiac resynchronization therapy. Eur Heart J 29: 2497-2505.
12. Makki N, Swaminathan PD, Olshansky B (2013) Does cardiac resynchronization therapy benefit patients with ischemic and non-ischemic cardiomyopathy similarly? Int J Cardiol 168: 4378-4380.
13. Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6: e1000097.
14. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, et al. (2000) Metaanalysis of observational studies in epidemiology: a proposal for reporting. Metaanalysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 283: 2008-2012. (Pubitemid 30214957)
15. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, et al. (1996) Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17: 1-12. (Pubitemid 26120810)
16. BMJ Publishing Group. (2012) A glossary of EBM terms. Clinical Evidence. Available:http://www.clinicalevidence.com/x/set/static/ebm/toolbox/678178.html. Accessed 20 September 2012.
17. Willi C, Bodenmann P, Ghali WA, Faris PD, Cornuz J (2007) Active smoking and the risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 298: 2654-2664. (Pubitemid 350254957)
18. Pan A, Sun Q, Okereke OI, Rexrode KM, Hu FB (2011) Depression and risk of stroke morbidity and mortality: a meta-analysis and systematic review. JAMA 306: 1241-1249.
19. Cazeau S, Leclercq C, Lavergne T, Walker S, Varma C, et al. (2001) Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med 344: 873-880. (Pubitemid 32224395)
20. Abraham WT, Fisher WG, Smith AL, Delurgio DB, Leon AR, et al. (2002) Cardiac resynchronization in chronic heart failure. N Engl J Med 346: 1845-1853. (Pubitemid 34603028)
21. Linde C, Abraham WT, Gold MR, St JSM, Ghio S, et al. (2008) Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms. J Am Coll Cardiol 52: 1834-1843.
22. Moss AJ, Hall WJ, Cannom DS, Klein H, Brown MW, et al. (2009) Cardiacresynchronization therapy for the prevention of heart-failure events.NEngl J Med 361: 1329-1338.
23. Tang AS, Wells GA, Talajic M, Arnold MO, Sheldon R, et al. (2010) Cardiacresynchronization therapy for mild-to-moderate heart failure. N Engl J Med 363: 2385-2395.
24. Duncan A, Wait D, Gibson D, Daubert JC (2003) Left ventricular remodelling and haemodynamic effects of multisite biventricular pacing in patients with left ventricular systolic dysfunction and activation disturbances in sinus rhythm: substudy of the MUSTIC (Multisite Stimulationin Cardiomyopathies) trial. Eur Heart J 24: 430-441. (Pubitemid 36286186)
25. Sutton MG, Plappert T, Hilpisch KE, Abraham WT, Hayes DL, et al. (2006) Sustained reverse left ventricular structural remodeling with cardiac resynchronization at one year is a function of etiology: quantitative Doppler echocardiographic evidence from the Multicenter InSync Randomized Clinical Evaluation (MIRACLE). Circulation 113: 266-272.
26. Wikstrom G, Blomstrom-Lundqvist C, Andren B, Lonnerholm S, Blomstrom P, et al. (2009) The effects of aetiology on outcome in patients treated with cardiac resynchronization therapy in the CARE-HF trial. Eur Heart J 30: 782-788.
27. Linde C, Abraham WT, Gold MR, Daubert C (2010) Cardiac resynchronization therapy in asymptomatic or mildly symptomatic heart failure patients in relation to etiology: results from the REVERSE (REsynchronization reVErses Remodeling in Systolic Left vEntricular Dysfunction) study. J Am Coll Cardiol 56: 1826-1831.
28. Barsheshet A, Goldenberg I, Moss AJ, Eldar M, Huang DT, et al. (2011) Response to preventive cardiac resynchronization therapy in patients with ischaemic and nonischaemic cardiomyopathy in MADIT-CRT. Eur Heart J 32: 1622-1630.
29. Molhoek SG, Bax JJ, van Erven L, Bootsma M, Boersma E, et al. (2004) Comparison of benefits from cardiac resynchronization therapy in patients with ischemic cardiomyopathy versus idiopathic dilated cardiomyopathy. Am J Cardiol 93: 860-863. (Pubitemid 38429597)
30. Leclercq C, Gras D, Tang A, Alonso C, Thomas-Revault DF, et al. (2004) Comparative effects of ventricular resynchronization therapy in heart failure patients with or without coronary artery disease. Ann Cardiol Angeiol (Paris) 53: 171-176. (Pubitemid 38798119)
31. Soliman OI, Theuns DA, Ten CF, Anwar AM, Nemes A, et al. (2007) Baseline predictors of cardiac events after cardiac resynchronization therapy in patients with heart failure secondary to ischemic or nonischemic etiology. Am J Cardiol 100: 464-469. (Pubitemid 47094697)
32. D'Andrea A, Caso P, Romano S, Scarafile R, Riegler L, et al. (2007) Different effects of cardiac resynchronization therapy on left atrial function in patients with either idiopathic or ischaemic dilated cardiomyopathy: a two-dimensional speckle strain study. Eur Heart J 28: 2738-2748. (Pubitemid 350135540)
33. Vidal B, Sitges M, Delgado V, Mont L, Diaz-Infante E, et al. (2007) [Influence of cardiopathy etiology on responses to cardiac resynchronization therapy]. Rev Esp Cardiol 60: 1264-1271. (Pubitemid 350294326)
34. Marsan NA, Bleeker GB, van Bommel RJ, Ypenburg C, Delgado V, et al. (2009) Comparison of time course of response to cardiac resynchronization therapy in patients with ischemic versus nonischemic cardiomyopathy. Am J Cardiol 103: 690-694.
35. Boriani G, Gasparini M, Landolina M, Lunati M, Biffi M, et al. (2009) Effectiveness of cardiac resynchronization therapy in heart failure patients with valvular heart disease: comparison with patients affected by ischaemic heart disease or dilated cardiomyopathy. The InSync/InSync ICD Italian Registry. Eur Heart J 30: 2275-2283.
36. Zhang Q, Fung JW, Chan JY, Yip G, Lam YY, et al. (2009) Difference in longterm clinical outcome after cardiac resynchronisation therapy between ischaemic and non-ischaemic aetiologies of heart failure. Heart 95: 113-118.
37. Kazemi Saeid A, Bozorgi A, Davoodi G, Sadeghian S, Yaminisharif A, et al. (2011) Comparison of Benefits from Cardiac Resynchronization Therapy between Patients with Ischemic Cardiomyopathy and Patients with Idiopathic Dilated Cardiomyopathy. Journal of Tehran University Heart Center; Vol 4, No 2 (2009).
38. McLeod CJ, Shen WK, Rea RF, Friedman PA, Hayes DL, et al. (2011) Differential outcome of cardiac resynchronization therapy in ischemic cardiomyopathy and idiopathic dilated cardiomyopathy. Heart Rhythm 8: 377-382.
39. Zaca V, Baiocchi C, Gaddi R, Gentilini R, Lunghetti S, et al. (2011) Influence of aetiology on long-term effects of resynchronization on cardiac structure and function in patients treated with beta-blockers. J Cardiovasc Med (Hagerstown) 12: 227-233.
40. Assmann SF, Pocock SJ, Enos LE, Kasten LE (2000) Subgroup analysis and other (mis)uses of baseline data in clinical trials. Lancet 355: 1064-1069. (Pubitemid 30162810)
41. Follath F, Cleland JG, Klein W, Murphy R (1998) Etiology and response to drug treatment in heart failure. J Am Coll Cardiol 32: 1167-1172. (Pubitemid 28522369)
42. Bart BA, Shaw LK, McCants CJ, Fortin DF, Lee KL, et al. (1997) Clinical determinants of mortality in patients with angiographically diagnosed ischemic or nonischemic cardiomyopathy. J Am Coll Cardiol 30: 1002-1008. (Pubitemid 27435894)
43. Adelstein EC, Tanaka H, Soman P, Miske G, Haberman SC, et al. (2011) Impact of scar burden by single-photon emission computed tomography myocardial perfusion imaging on patient outcomes following cardiac resynchronization therapy. Eur Heart J 32: 93-103.